Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17678572 | 0.87 | CA2 (0.40) | CA2CA1CA12CA9CA4 | |
| SCHEMBL17680121 | 0.85 | CA2 (0.39) | CA2CA1CA12CA9CA4 | |
| SCHEMBL5848176 | 0.85 | CA2 (0.41) | CA2CA1CA12CA9CA4 | |
| Hydrochloric Acid SCHEMBL28172394 | 0.83 | CA2 (0.40) | CA2CA1CA12CA9CA4 | |
| SCHEMBL2057902 | 0.82 | CA2 (0.44) | CA2CA1CA12CA9CA4 | |
| SCHEMBL28661455 | 0.77 | CA2 (0.46) | CA2CA1CA12CA9CA4 | |
| SCHEMBL13324786 | 0.77 | ESR1 (0.50) | CA2LMNAALDH1A1TDP1 | |
| SCHEMBL2057417 | 0.76 | CA2 (0.43) | CA2CA1CA12CA9CA4 | |
| SCHEMBL11583429 | 0.75 | LMNA (0.56) | CA2CA1CA12CA9CA4 | |
| SCHEMBL11396462 | 0.75 | LMNA (0.43) | CA2CA1CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140024127-A1 | METHODS FOR RECOVERING AND ANALYZING AMINES | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20140024127-A1 | METHODS FOR RECOVERING AND ANALYZING AMINES | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-01-23 | — | — | US | disclosed |
| EP-2687278-A1 | Methods for recovering and analyzing amines | Kabushiki Kaisha Toshiba (JP) | 2014-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024127-A1 | METHODS FOR RECOVERING AND ANALYZING AMINES | METTL3, PNMT, PRMT3 | CA2 509/4885CA1 196/4885CA12 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.